An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext

Stopped early · Phase 2

Conditions studied: Uterine Fibroids

In brief

An open label, extension study for subjects completing the ZPU-003 Ext 1 study.

Key facts

Study ID

NCT00958893

Run by

Repros Therapeutics Inc.

People needed

4

Starts

2008-06-01

Expected to finish

2009-08-01

Last updated by the study team

2014-08-25

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Four subjects at one site whom have completed ZPU 003 Ext 1 study

You may not qualify if…

• All other subjects

Where it is running

• Advances in Health, Inc. — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.